Moneycontrol PRO
HomeNewsAurobindopharma
Jump to
  • Buy Aurobindo Pharma; target of Rs 1010: Centrum

    Centrum bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1010 in its research report dated August 13, 2018.

  • Buy Aurobindo Pharma; target of Rs 691: HDFC Securities

    Buy Aurobindo Pharma; target of Rs 691: HDFC Securities

    HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 691 in its research report dated August 11, 2018.

  • Buy Aurobindo Pharma; target of Rs 750: Motilal Oswal

    Buy Aurobindo Pharma; target of Rs 750: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 750 in its research report dated August 10, 2018.

  • Buy Aurobindo Pharma; target of Rs 685: ICICI Direct

    Buy Aurobindo Pharma; target of Rs 685: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 685 in its research report dated August 10, 2018.

  • Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated August 01, 2018.

  • Buy Aurobindo Pharma; target of Rs 1070: Centrum Research

    Buy Aurobindo Pharma; target of Rs 1070: Centrum Research

    Centrum Research is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated June 04, 2018.

  • Buy Aurobindo Pharma; target of Rs 800: Khambatta Securities

    Buy Aurobindo Pharma; target of Rs 800: Khambatta Securities

    Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated May 30, 2018.

  • Buy Aurobindo Pharma; target of Rs 1070: Centrum

    Buy Aurobindo Pharma; target of Rs 1070: Centrum

    Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated June 04,2018

  • Hold Aurobindo Pharma; target of Rs 630: Edelweiss

    Hold Aurobindo Pharma; target of Rs 630: Edelweiss

    Edelweiss recommended hold rating on Aurobindo Pharma with a target price of Rs 630 in its research report dated May 29, 2018.

  • Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated May 21, 2018.

  • Accumulate Aurobindo Pharma; target of Rs 728: Arihant Capital

    Accumulate Aurobindo Pharma; target of Rs 728: Arihant Capital

    Arihant Capital recommended accumulate rating on Aurobindo Pharma with a target price of Rs 728 in its research report dated April 10, 2018.

  • Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Buy Aurobindo Pharma; target of Rs 909: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated February 09, 2018.

  • Buy Aurobindo Pharma; target of Rs 904: Khambatta Securities

    Buy Aurobindo Pharma; target of Rs 904: Khambatta Securities

    Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 904 in its research report dated November 13, 2017.

  • Buy Aurobindo Pharma; target of Rs 1030: Centrum

    Buy Aurobindo Pharma; target of Rs 1030: Centrum

    Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 10, 2017.

  • Buy Aurobindo Pharma; target of Rs 817: Geojit

    Buy Aurobindo Pharma; target of Rs 817: Geojit

    Geojit has recommended buy rating on Aurobindo Pharma with a target price of Rs 817 in its research report dated 1 September 2017.

  • Buy Aurobindo Pharma; target of Rs 800: Khambatta Securities

    Buy Aurobindo Pharma; target of Rs 800: Khambatta Securities

    Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated August 11, 2017.

  • Buy Aurobindo; target of Rs 825: Axis Direct

    Buy Aurobindo; target of Rs 825: Axis Direct

    Axis Direct is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 16, 2017.

  • Buy Aurobindo Pharma; target of Rs 850: Axis Direct

    Buy Aurobindo Pharma; target of Rs 850: Axis Direct

    Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24, 2017.

  • Buy Aurobindo Pharma; target of Rs 850: Motilal Oswal

    Buy Aurobindo Pharma; target of Rs 850: Motilal Oswal

    Motilal Oswal recommended buy rating on Aurobindo Pharma with a target price of Rs 850 in its research report dated July 19, 2017.

  • Buy Aurobindo Pharma; target of Rs 700: Reliance Securities

    Buy Aurobindo Pharma; target of Rs 700: Reliance Securities

    Reliance Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 700 in its research report dated May 30, 2017.

  • Buy Aurobindo; target of Rs 740: HDFC Securities

    Buy Aurobindo; target of Rs 740: HDFC Securities

    HDFC Securities is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 30, 2017.

  • Hold Aurobindo Pharma; target of Rs 640: Edelweiss

    Hold Aurobindo Pharma; target of Rs 640: Edelweiss

    Edelweiss recommended hold rating on Aurobindo Pharma with a target price of Rs 640 in its research report dated May 30, 2017.

  • Buy Aurobindo Pharma; target of Rs 753: ICICI Direct

    Buy Aurobindo Pharma; target of Rs 753: ICICI Direct

    ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 753 in its research report dated May 31, 2017.

  • Buy Aurobindo Pharma; target of Rs 900: Motilal Oswal

    Buy Aurobindo Pharma; target of Rs 900: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 09, 2017.

  • Buy Aurobindo Pharma; target of Rs 900: Motilal Oswal

    Buy Aurobindo Pharma; target of Rs 900: Motilal Oswal

    Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 04, 2017.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347